Skip to main content
. Author manuscript; available in PMC: 2012 Sep 17.
Published in final edited form as: J Matern Fetal Neonatal Med. 2011 Jun 1;25(4):379–384. doi: 10.3109/14767058.2011.580402

Table I.

Maternal characteristics associated with women with GDM who were treated with either subcutaneous insulin or glyburide.

Insulin
injections
(%),
(n = 8609)
Glyburide
(%),
(n = 2073)
p value
Parity
  Nulliparas (n = 2037) 77.5 22.5 p < 0.001
  Multiparas (n = 8167) 81.5 18.5
Age
  Maternal age < 19 (n = 104) 82.7 17.3 p < 0.001
  Maternal age 20–34 (n = 5676) 79.1 20.9
  Maternal age >35 (n = 4484) 82.5 17.5
Race/Ethnicity
  White (n = 2278) 81.9 18.1 p < 0.001
  African American (n = 385) 77.7 22.3
  Latina/Hispanic (n = 5450) 81.1 18.9
  Asian (n = 1616) 75.1 24.9
  Other (n = 488) 83.2 16.8
Body mass index (kg/m2)
  <19.8 (n = 48) 75 25 p < 0.001
  19.8–26.0 (n = 1774) 77.3 22.7
  26.1–29.0 (n = 2719) 79.3 20.7
  >29.0 (n = 5475) 82.2 17.8
Gestational age at GDM diagnosis
  < 20 weeks (n = 1004) 80.3 19.7 p = 0.001
  20–32 weeks (n = 3985) 78.7 21.3
  ≥33 weeks (n = 147) 82.9 17.1
Education (years)
  0–8 years (<high school; n = 1619) 80 20 p < 0.001
  9–12 years (high school; n = 4934) 77.8 22.2
  >12 years (college and above; n = 2964) 83.4 16.6
Primary language
  English (n = 5594) 82.9 17.2 p < 0.001
  Spanish (n = 3848) 79.6 20.4
  Other (n = 1056) 73.9 26.1